Thursday, June 19, 2008
Wednesday, June 18, 2008
How Prozac killed poetry: Leonard Cohen on antidepressants
"It's been 15 years since I stood up on the stage. Fifteen years ago when I was 60 - a young kid with a crazy dream - then I took a lot of Prozac." Then he reeled off the names of other prescription mood-enhancers he had taken over the years.
Did Leonard Cohen lose 15 years to antidepressants?
Tuesday, June 17, 2008
Monday, June 16, 2008
Sunday, June 15, 2008
The Globalization of Pharma
Click on image to enlarge
India, China Becoming Centers of Pharmaceutical R&D, Study Finds
Big pharmaceutical companies such as Merck, Eli Lilly, and Johnson & Johnson are increasingly relying on China and India for advanced research and development, a new study funded by the Ewing Marion Kauffman Foundation finds.
According to the study, The Globalization of Innovation: Pharmaceuticals; Can India and China Cure the Global Pharmaceutical Market? (67 pages, PDF), Indian and Chinese scientists are rapidly developing the ability to innovate and create their own intellectual property as a result of multinational pharmaceutical companies moving R&D operations to their countries. The symbiotic relationships have enabled multinational firms to cut costs and broaden capacity while pharmaceutical firms in China and India gain revenue and develop expertise. In 2006, 5.5 percent of all global pharmaceutical patent applications named one or more inventors located in India, while 8.4 percent named one or more located in China — a fourfold increase from 1995.
In the study, the authors analyzed the business models, value-chain activities, partnerships, and technology capabilities of more than a hundred Chinese and Indian pharmaceutical firms. They found Indian and Chinese companies were making strides in the most lucrative segments of global value chains, while also prevailing in less lucrative segments, such as preclinical testing, animal experimentation, and manufacturing. However, since firms in those countries rarely have the capital and the regulatory expertise to develop a drug beyond phase II clinical trials, the commercial development of new intellectual property necessitates relationships with major multinational corporations.
from http://foundationcenter.org
pdf here
Saturday, June 14, 2008
From Heroin to Methadone
Heroin used to be a big - and legal - seller for Bayer. Now a big moneymaker for Eli Lilly and other Pharma companies is Methadone.
However, Methadone is not needed if addicts are permitted to withdraw with Vitamin C.
Look at this introduction to the work of Dr. Alexander Schauss - pdf here - and learn about the Opium Wars here - and follow the money.
From the New York Times: Legal drugs cause more deaths than illegal ones.
No surprise....
Subscribe to:
Posts (Atom)
Posts
